Mixohipra-FSA suspensão após reconstituição do liofilizado para coelhos
Mixohipra-FSA suspensão após reconstituição do liofilizado para coelhos
Authorised
- Shope fibroma virus, Live
Product identification
Medicine name:
Mixohipra-FSA suspensão após reconstituição do liofilizado para coelhos
Active substance:
- Shope fibroma virus, Live
Target species:
-
Rabbit
Route of administration:
-
Intradermal use
-
Subcutaneous use
Product details
Active substance and strength:
-
Shope fibroma virus, Live1.00/50% cell culture infectious dose0.50millilitre(s)
Pharmaceutical form:
-
Lyophilisate for suspension for injection
Withdrawal period by route of administration:
-
Intradermal use
-
Rabbit
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Rabbit
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 267/89 DGV
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 9/01/2026